ALT Announces $211.2M Offering: 64.25M Shares @ $3.00, 10.75M Pre-Funded Warrants @ $2.999, Net Proceeds $211.2M for MASH Phase 3, Pre-Commercial, Corporate Use
Altimmune, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $3.01
-7.7% in 3d after detection
Post-detection moves
1h
—
1d
-1.8%
3d
-7.7%
7d
+7.4%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS